• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受溶栓治疗的被误诊为视网膜中央动脉阻塞患者的眼内出血

Intraocular hemorrhage in patients misdiagnosed with central retinal artery occlusion treated with thrombolysis.

作者信息

Adamkiewicz Daniel V, Leal Christian, Yan Kevin Y, Arepalli Sruthi, Ferenchak Kevin, Cribbs Blaine, Lyons Riley J, Bénard-Séguin Étienne, Newman Nancy J, Biousse Valérie

机构信息

Department of Ophthalmology, Emory University School of Medicine, Atlanta, GA, United States.

Department of Surgery, Section of Ophthalmology, University of Calgary, Calgary, AB, Canada.

出版信息

Front Neurol. 2025 Aug 20;16:1631546. doi: 10.3389/fneur.2025.1631546. eCollection 2025.

DOI:10.3389/fneur.2025.1631546
PMID:40909000
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12404925/
Abstract

INTRODUCTION

The diagnosis of acute central retinal artery occlusion (CRAO) is commonly delayed in emergency departments (ED) where ophthalmologists are rarely available for immediate consultation. Thrombolysis is sometimes given empirically for presumed CRAO without confirmation of the diagnosis with ocular funduscopic examination.

METHODS

We describe one case of severe intraocular hemorrhage following intravenous thrombolysis for a retinal detachment misdiagnosed as a CRAO, and two cases of worsening intraocular hemorrhage following intravenous thrombolysis for misdiagnosed CRAO, and review the literature.

RESULTS

We identified 4 cases in the literature were thrombolysis given for RAO resulted in ocular hemorrhage. We identified 12 additional cases where thrombolysis given for any indication resulted in intraocular hemorrhage.

DISCUSSION

Ocular hemorrhage is a rare but potentially devastating complication of thrombolysis in patients with underlying retinal disorders other than CRAO. Thrombolysis should never be given for acute vision loss without a funduscopic examination or ocular imaging confirming the diagnosis of CRAO.

摘要

引言

急性视网膜中央动脉阻塞(CRAO)的诊断在急诊科通常会延迟,因为那里很少有眼科医生可供即时会诊。对于疑似CRAO的患者,有时在未通过眼底检查确诊的情况下就凭经验进行溶栓治疗。

方法

我们描述了1例因视网膜脱离被误诊为CRAO而进行静脉溶栓后发生严重眼内出血的病例,以及2例因CRAO误诊而进行静脉溶栓后眼内出血加重的病例,并对相关文献进行了回顾。

结果

我们在文献中发现4例因视网膜动脉阻塞(RAO)进行溶栓治疗导致眼内出血的病例。我们还另外发现12例因任何适应症进行溶栓治疗导致眼内出血的病例。

讨论

眼内出血是除CRAO外患有潜在视网膜疾病患者溶栓治疗罕见但可能具有毁灭性的并发症。在没有眼底检查或眼部成像确认CRAO诊断的情况下,绝不应因急性视力丧失而进行溶栓治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7876/12404925/2b9897e01aab/fneur-16-1631546-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7876/12404925/43904dc3ade1/fneur-16-1631546-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7876/12404925/8756e4ac20be/fneur-16-1631546-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7876/12404925/2b9897e01aab/fneur-16-1631546-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7876/12404925/43904dc3ade1/fneur-16-1631546-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7876/12404925/8756e4ac20be/fneur-16-1631546-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7876/12404925/2b9897e01aab/fneur-16-1631546-g003.jpg

相似文献

1
Intraocular hemorrhage in patients misdiagnosed with central retinal artery occlusion treated with thrombolysis.接受溶栓治疗的被误诊为视网膜中央动脉阻塞患者的眼内出血
Front Neurol. 2025 Aug 20;16:1631546. doi: 10.3389/fneur.2025.1631546. eCollection 2025.
2
Interventions for acute non-arteritic central retinal artery occlusion.急性非动脉炎性视网膜中央动脉阻塞的治疗。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD001989. doi: 10.1002/14651858.CD001989.pub3.
3
[The application of superselective ophthalmic artery thrombolysis in the treatment of central retinal artery occlusion].[超选择性眼动脉溶栓术在视网膜中央动脉阻塞治疗中的应用]
Zhonghua Wai Ke Za Zhi. 2025 Jul 30;63(9):842-849. doi: 10.3760/cma.j.cn112139-20250227-00096.
4
Intravenous thrombolysis in patients with central retinal artery occlusion: a systematic review and meta-analysis.视网膜中央动脉阻塞患者的静脉溶栓治疗:系统评价与荟萃分析。
J Neurol. 2022 Apr;269(4):1825-1833. doi: 10.1007/s00415-021-10838-6. Epub 2021 Oct 9.
5
Safety of intravenous thrombolysis in central retinal artery occlusion patients with concomitant acute cerebral infarctions.伴有急性脑梗死的视网膜中央动脉阻塞患者静脉溶栓的安全性
J Neurol Sci. 2025 Apr 15;471:123441. doi: 10.1016/j.jns.2025.123441. Epub 2025 Feb 28.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
Catheter-directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute pulmonary embolism.经导管治疗高危(大块)和中危(次大块)急性肺栓塞。
Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD013083. doi: 10.1002/14651858.CD013083.pub2.
8
Migraine May Represent an Independent Risk Factor for Retinal Stroke: A Population-Based Cohort Study.偏头痛可能是视网膜卒中的独立危险因素:基于人群的队列研究。
Clin Neurol Neurosurg. 2024 Nov;246:108587. doi: 10.1016/j.clineuro.2024.108587. Epub 2024 Oct 10.
9
The effects of hyperbaric oxygen treatment for non-arteritic central retinal artery occlusion (HBOT-CRAO).高压氧治疗非动脉炎性视网膜中央动脉阻塞(HBOT-CRAO)的效果
Am J Emerg Med. 2025 Aug 5;98:1-5. doi: 10.1016/j.ajem.2025.07.065.
10
Infusion techniques for peripheral arterial thrombolysis.外周动脉溶栓的输注技术。
Cochrane Database Syst Rev. 2021 Nov 17;11(11):CD000985. doi: 10.1002/14651858.CD000985.pub3.

本文引用的文献

1
Retinal and Ophthalmic Artery Occlusions Preferred Practice Pattern®.视网膜和眼动脉阻塞首选诊疗模式®
Ophthalmology. 2025 Apr;132(4):P270-P302. doi: 10.1016/j.ophtha.2024.12.024. Epub 2025 Feb 7.
2
A telemedicine-enabled intravenous thrombolytic treatment pathway for patients with hyperacute non-arteritic central retinal artery occlusion.一种用于超急性非动脉性视网膜中央动脉阻塞患者的远程医疗静脉溶栓治疗途径。
Am J Ophthalmol Case Rep. 2024 Oct 20;36:102204. doi: 10.1016/j.ajoc.2024.102204. eCollection 2024 Dec.
3
Breaking the barriers: Methodology of implementation of a non-mydriatic ocular fundus camera in an emergency department.
打破障碍:在急诊科实施非散瞳眼底相机的方法。
Surv Ophthalmol. 2025 Jan-Feb;70(1):153-161. doi: 10.1016/j.survophthal.2024.09.012. Epub 2024 Sep 30.
4
Remote Diagnosis of Retinal Detachment in an Emergency Department Using Nonmydriatic Hybrid Ocular Imaging.急诊科使用非散瞳混合眼部成像技术对视网膜脱离进行远程诊断。
Telemed J E Health. 2025 Feb;31(2):185-190. doi: 10.1089/tmj.2024.0435. Epub 2024 Sep 30.
5
Tenecteplase vs Alteplase for Patients With Acute Ischemic Stroke: The ORIGINAL Randomized Clinical Trial.替奈普酶与阿替普酶治疗急性缺血性卒中患者:ORIGINAL随机临床试验
JAMA. 2024 Nov 5;332(17):1437-1445. doi: 10.1001/jama.2024.14721.
6
Eye stroke protocol in in the emergency department.眼科急症处理规程。
J Stroke Cerebrovasc Dis. 2024 Sep;33(9):107895. doi: 10.1016/j.jstrokecerebrovasdis.2024.107895. Epub 2024 Jul 28.
7
Central retinal artery occlusion or retinal stroke: a neurosonologist's perspective.视网膜中央动脉阻塞或视网膜中风:神经超声专家的观点
Front Neurol. 2024 Jun 10;15:1397751. doi: 10.3389/fneur.2024.1397751. eCollection 2024.
8
Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy.替奈普酶治疗发病 4.5 至 24 小时内的缺血性脑卒中且未进行取栓治疗。
N Engl J Med. 2024 Jul 18;391(3):203-212. doi: 10.1056/NEJMoa2402980. Epub 2024 Jun 14.
9
A Remote Consult Retinal Artery Occlusion Diagnostic Protocol.远程会诊视网膜动脉阻塞诊断方案
Ophthalmology. 2024 Jun;131(6):724-730. doi: 10.1016/j.ophtha.2023.11.031. Epub 2024 Feb 13.
10
Reteplase versus alteplase for acute ischaemic stroke within 4.5 hours (RAISE): rationale and design of a multicentre, prospective, randomised, open-label, blinded-endpoint, controlled phase 3 non-inferiority trial.瑞替普酶与阿替普酶治疗 4.5 小时内急性缺血性脑卒中(RAISE):一项多中心、前瞻性、随机、开放标签、盲终点、对照 3 期非劣效性试验的原理和设计。
Stroke Vasc Neurol. 2024 Nov 5;9(5):568-573. doi: 10.1136/svn-2023-003035.